Evaluation of the effect of Colchicine in the patients with Acute Coroanry Syndrome

Phase 3

• Conditions: Acute Coronary Syndrome.; ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

• Registration Number: IRCT20201117049420N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Patients who have completed the informed consent form
Patients aged 40-70 years with history of chest pain who have undergone Coronary Angiography with the aim of medical treatment or who have undergone Total or Near Total Revascularization
Whose information and follow ups are completed

Exclusion Criteria

1. Patients with history of hypersensitivity to Colchicine
2. Patients with history of Moderate Renal Dysfunction (GFR<50)
3. Patients with history of Hepatic Dysfunction (ALT> 1.5 * ULN)
4. Patients with history of Thrombocytopenia and or Leukopenia
5. Pregnant patient, Lactating women, and women at risk of Pregnancy
6. Patients who are already taking Colchicine
7. Patients who have undergone CABG (Coronary Artery Bypass Grafting)
8. Patients with LVEF less than 30%

Study & Design

• Study Type: interventional
• Study Design: Not specified